Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant new » significant non (Expand Search), significant genes (Expand Search), significant anti (Expand Search)
new decrease » nn decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant new » significant non (Expand Search), significant genes (Expand Search), significant anti (Expand Search)
new decrease » nn decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
-
3761
-
3762
Line graph showing the values of inflammatory cytokines at baseline and after treatment.
Published 2025Subjects: -
3763
Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness.
Published 2024Subjects: -
3764
-
3765
-
3766
-
3767
-
3768
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3769
-
3770
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
3771
-
3772
-
3773
-
3774
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
3775
-
3776
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
3777
Relative abundance of microbiota in colonic content at the genus level (n = 5).
Published 2025Subjects: -
3778
-
3779
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
3780
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: